1-3 of 3
Rashid Abassi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subcutaneous Injections of Low Doses of Humanized Anti-CD20 Veltuzumab for Treatment of Indolent B-Cell Malignancies.

O. George Negrea, MD, Steven L Allen, Kanti R. Rai, MD, Rebecca Elstrom, MD, Rashid Abassi, MD, Charles M Farber, MD, PhD, Nick Teoh, PhD, Heather Horne, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD
Journal: Blood
Blood (2009) 114 (22): 3757.
https://doi.org/10.1182/blood.V114.22.3757.3757
Published: 2009
Journal Articles

Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab for Treatment of Relapsed Immune Thrombocytopenia (ITP).

Mansoor N Saleh, MD, Howard Liebman, MD, Zale P. Bernstein, MD, O. George Negrea, MD, James B. Bussel, MD, Anthony C. Onyegbula, DO, Charles M Farber, MD, PhD, Rashid Abassi, MD, Thomas M. Cosgriff, MD, Kenneth Pennington, MD, Heather Horne, Nick Teoh, PhD, Asraf Gomaa, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD
Journal: Blood
Blood (2009) 114 (22): 1322.
https://doi.org/10.1182/blood.V114.22.1322.1322
Published: 2009
Journal Articles

Low-Dose Humanized Anti-CD20 Monoclonal Antibody (MAb), Veltuzumab, in Adult Immune Thrombocytopenic Purpura (ITP): Initial Results of a Phase I/II Study.

Howard A. Liebman, MA, MD, Mansoor N. Saleh, MD, Rashid Abassi, MD, Thomas M. Cosgriff, MD, Nick Teoh, PhD, Matthew J Leoni, MD, William Wegener, MD, PhD, David M Goldenberg, ScD, MD
Journal: Blood
Blood (2008) 112 (11): 3412.
https://doi.org/10.1182/blood.V112.11.3412.3412
Published: 2008